Our Oncology Clinical Strategy is designed to transform survival

Home / Our therapy areas / Oncology / Clinical Strategy

At AstraZeneca, we think differently about the underlying genetic causes of cancer. Our clinical strategy aims to transform survival by seeking to combat metastatic and resistant disease and providing options to treat early. We are defining new biomarkers and therapeutic targets that cut across multiple tumour types. We are transforming the way people with cancer are diagnosed and treated by looking in new places, beyond traditional classifications and focusing on the properties of a tumour, not just its type.

Introduction to our clinical strategy

Our clinical stratgy is designed to transform survival. We aim to combat cancer at all stages, but we know that the earlier we can detect and address cancer, the closer we may be to better outcomes.

Latest Oncology News

Explore our Oncology pillars

Veeva ID: Z4-40328
Date of preparation: November 2021